123 related articles for article (PubMed ID: 26699515)
1. Highly Effective and Hydrolytically Stable Vanadium(V) Amino Phenolato Antitumor Agents.
Reytman L; Braitbard O; Hochman J; Tshuva EY
Inorg Chem; 2016 Jan; 55(2):610-8. PubMed ID: 26699515
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
3. Highly cytotoxic vanadium(V) complexes of salan ligands; insights on the role of hydrolysis.
Reytman L; Braitbard O; Tshuva EY
Dalton Trans; 2012 May; 41(17):5241-7. PubMed ID: 22415291
[TBL] [Abstract][Full Text] [Related]
4. Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.
Peri D; Meker S; Manna CM; Tshuva EY
Inorg Chem; 2011 Feb; 50(3):1030-8. PubMed ID: 21214265
[TBL] [Abstract][Full Text] [Related]
5. Specific Design of Titanium(IV) Phenolato Chelates Yields Stable and Accessible, Effective and Selective Anticancer Agents.
Meker S; Braitbard O; Hall MD; Hochman J; Tshuva EY
Chemistry; 2016 Jul; 22(29):9986-95. PubMed ID: 27320784
[TBL] [Abstract][Full Text] [Related]
6. Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and Selectivity.
Meker S; Braitbard O; Margulis-Goshen K; Magdassi S; Hochman J; Tshuva EY
Molecules; 2015 Oct; 20(10):18526-38. PubMed ID: 26473816
[TBL] [Abstract][Full Text] [Related]
7. Hydrolytically Stable and Cytotoxic [ONO
Pedko A; Rubanovich E; Tshuva EY; Shurki A
Inorg Chem; 2022 Nov; 61(44):17653-17661. PubMed ID: 36273341
[TBL] [Abstract][Full Text] [Related]
8. Complexes of N-hydroxyethyl-N-benzimidazolylmethylethylenediaminediacetic acid with group 12 metals and vanadium-Synthesis, structure and bioactivity of the vanadium complex.
Habala L; Bartel C; Giester G; Jakupec MA; Keppler BK; Rompel A
J Inorg Biochem; 2015 Jun; 147():147-52. PubMed ID: 25920686
[TBL] [Abstract][Full Text] [Related]
9. Water soluble heterometallic potassium-dioxidovanadium(V) complexes as potential antiproliferative agents.
Sutradhar M; Fernandes AR; Silva J; Mahmudov KT; Guedes da Silva MF; Pombeiro AJ
J Inorg Biochem; 2016 Feb; 155():17-25. PubMed ID: 26606289
[TBL] [Abstract][Full Text] [Related]
10. Phenolato Ti(IV) hexacoordinate complexes for anticancer chemotherapy: enhancement of solubility, hydrolytic stability, and cytotoxicity.
Taha M; Tshuva EY
Dalton Trans; 2023 Jun; 52(22):7664-7672. PubMed ID: 37199994
[TBL] [Abstract][Full Text] [Related]
11. Trans titanium(IV) complexes of salen ligands exhibit high antitumor activity.
Tzubery A; Tshuva EY
Inorg Chem; 2011 Sep; 50(17):7946-8. PubMed ID: 21797239
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic salan-titanium(IV) complexes: high activity toward a range of sensitive and drug-resistant cell lines, and mechanistic insights.
Manna CM; Braitbard O; Weiss E; Hochman J; Tshuva EY
ChemMedChem; 2012 Apr; 7(4):703-8. PubMed ID: 22262543
[TBL] [Abstract][Full Text] [Related]
13. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties.
Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC
J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity and hydrolysis of trans-Ti(IV) complexes of salen ligands: structure-activity relationship studies.
Tzubery A; Tshuva EY
Inorg Chem; 2012 Feb; 51(3):1796-804. PubMed ID: 22220885
[TBL] [Abstract][Full Text] [Related]
15. Antitumor reactivity of non-metallocene titanium complexes of oxygen-based ligands: is ligand lability essential?
Shavit M; Peri D; Melman A; Tshuva EY
J Biol Inorg Chem; 2007 Aug; 12(6):825-30. PubMed ID: 17483967
[TBL] [Abstract][Full Text] [Related]
16. Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements.
Benítez J; Becco L; Correia I; Leal SM; Guiset H; Pessoa JC; Lorenzo J; Tanco S; Escobar P; Moreno V; Garat B; Gambino D
J Inorg Biochem; 2011 Feb; 105(2):303-12. PubMed ID: 21194632
[TBL] [Abstract][Full Text] [Related]
17. A Short-Lived but Highly Cytotoxic Vanadium(V) Complex as a Potential Drug Lead for Brain Cancer Treatment by Intratumoral Injections.
Levina A; Pires Vieira A; Wijetunga A; Kaur R; Koehn JT; Crans DC; Lay PA
Angew Chem Int Ed Engl; 2020 Sep; 59(37):15834-15838. PubMed ID: 32598089
[TBL] [Abstract][Full Text] [Related]
18. Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 1. Coordination modes and geometry in solution and at the physiological pH.
Sanna D; Ugone V; Lubinu G; Micera G; Garribba E
J Inorg Biochem; 2014 Nov; 140():173-84. PubMed ID: 25127230
[TBL] [Abstract][Full Text] [Related]
19. Low-dimensional compounds containing bioactive ligands. V: Synthesis and characterization of novel anticancer Pd(II) ionic compounds with quinolin-8-ol halogen derivatives.
Vranec P; Potočňák I; Sabolová D; Farkasová V; Ipóthová Z; Pisarčíková J; Paulíková H
J Inorg Biochem; 2014 Feb; 131():37-46. PubMed ID: 24239911
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
